All articles by Adam Zamecnik

Adam Zamecnik


Adam Zamecnik is a healthcare reporter for Pharmaceutical Technology. He has covered diverse topics such as continuous drug manufacturing, genomic research and sexual health. He is particularly interested in new technologies, health inequality, and cell and gene therapy research.

UK rejoins EU’s Horizon Europe science programme

The country returns to the EU’s research programme after a Brexit-related absence and questions surrounding its re-entry prospects.

Tapping into digital therapeutics to improve neurological outcomes

Despite advancing research, clinical data and timely reimbursement are crucial for digital therapeutics in neurology.